Enabling Early Assessment Of Drug Targets To Maximize Clinical And Commercial Success
Source: Syngene International Ltd.
Target identification and validation is a major challenge in the pharmaceutical industry, with many promising treatments failing in the clinic for efficacy or target-related safety issues. The reason is usually that the underlying hypothesis turns out to be wrong, or there are unwanted consequences to modulating the target. Comprehensive diligence around a target before starting a discovery program can make the difference between success and failure.
VIEW THE CASE STUDY! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online X
Subscribe to Drug Discovery Online